The largest database of trusted experimental protocols

Cy3 dctp

Manufactured by GE Healthcare
Sourced in United States, United Kingdom, Belgium

Cy3-dCTP is a nucleotide analog used in various molecular biology techniques. It is a fluorescently labeled form of the deoxycytidine triphosphate (dCTP) nucleotide, with the Cy3 fluorescent dye attached. Cy3-dCTP can be incorporated into DNA or RNA during synthesis, allowing for the detection and visualization of the labeled molecules.

Automatically generated - may contain errors

33 protocols using cy3 dctp

1

Fluorescent RNA Labeling and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
An amount of 2 μg of total RNA from each sample was reverse-transcribed and labeled directly with fluorescent dye. The 30-μl RT reaction mixture contained 5 μg of random primers, 40 U RNaseOUT™ Recombinant Ribonuclease Inhibitor, 6 μl 5x first-strand buffer, 3 μl of 100 mM DTT, 400 U SuperScript™ III Reverse Transcriptase (Invitrogen, Life Technologies Ltd, Paisley, UK), 0.6 μl dNTP mix (25 mM dATP, 25 mM dGTP, 25 mM dTTP, 10 mM dCTP [Promega Corporation, Madison, WI, USA]), and 2 nmol Cy3-dCTP or Cy5-dCTP (GE Healthcare, Buckinghamshire, UK). Each mixture was incubated for 3 h at 46°C and stopped with 1.5 μl of 20 mM EDTA. After addition of 15 μl of 0.1 M NaOH the RNA was hydrolyzed for 15 min at 70°C, followed by neutralization with 15 μl of 0.1 M HCl. The labeled cDNA was purified using a DNA purification column (QIAquick PCR purification kit; Qiagen) and eluted into 44 μl of elution buffer (Qiagen).
+ Open protocol
+ Expand
2

Transcriptome Analysis of Bacterial Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each replicate, 2 μg of RNA was labeled with Cy3 dCTP (GE Healthcare) using random primers (Invitrogen) and Superscript II reverse transcriptase (Invitrogen). Fluorescently labeled cDNAs were purified and hybridized onto BμG@S SAv2.1.0 microarrays provided by the Bacterial Microarray Group at St. George's, University of London, using a one-color microarray-based gene expression system. Washing, scanning, and feature extraction procedures were performed as described previously (42 (link)). Array design is available in BμG@Sbase (accession number A-BUGS-42) and also ArrayExpress (accession number A-BUGS-42). Statistical analyses were performed using GeneSpring (Agilent Technologies). Differentially expressed genes were defined as those that showed >2-fold up- or down-regulation with respect to the wild type, with a p value of <0.05 determined by two-way analysis of variance with Benjamini and Hochberg false discovery rate correction. A total of 465 differentially expressed genes were identified from the raw data, which was reduced to 307 genes once duplicate genes were removed. Fully annotated microarray data have been deposited in BμG@ base (accession number E-BUGS-158) and also ArrayExpress (accession number E-BUGS-158).
+ Open protocol
+ Expand
3

Profiling Differential lncRNA and mRNA Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
LncRNA and mRNA expressions were determined using a CapitaBio Technology Human LncRNA Array v4 (CapitalBio, Beijing, China). Double‐stranded complementary DNAs (cDNAs) were synthesized from 1 μg total RNA. cDNA was labeled with Cy3‐dCTP or Cy5‐dCTP (GE Healthcare, Piscataway, NJ) and hybridized onto a human lncRNA + mRNA Array V4.0 (4 × 180 K; Agilent, Santa Clara, CA), comprising 40,916 human lncRNAs and approximately 34,000 human mRNAs. The lncRNA and mRNA target sequences were merged from ENSEMBL, human long intervening/intergenic ncRNA, and the LNCipedia catalog.
Threshold values of ≥2 and ≤2‐fold change and a Benjamini‐Hochberg corrected p = .05 were used to identify differentially expressed genes. The data were analyzed using hierarchical clustering with average linkage. Java Treeview software (Stanford University School of Medicine, Stanford, CA) was employed to visualize the microarray results. The primers are listed in Table S1.
+ Open protocol
+ Expand
4

RNA Extraction and Microarray Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
TRIzol® Reagent (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA; cat. no. 15596-026); NucleoSpin® RNA clean-up (cat. no. 740.948.250); Nucleospin® Extract II (cat. no. 740.609.250; both Machery-Nagel, GmbH, Düren, Germany); GeeDom bio-chip universal label reagent (Capital Biotechnology, Co., Ltd., Beijing, China; cat. no. 360069); Cy3-dCTP (GE Healthcare, Chicago, IL, USA; cat. no. PA53031); Cy5-dCTP (GE Healthcare; cat. no. PA55031); 10% SDS; 20 × sodium citrate buffer (both Capital Biotechnology, Co., Ltd.); Agilent one-color RNA Spike-in kit (cat. no. 5188-5282); Agilent two-color RNA Spike-in kit (cat. no. 5188-5279; both Agilent Technologies Inc., Santa Clara, CA, USA); RNAiso Plus kit (Takara Biotechnology Co., Ltd., Dalian, China); TransScript One-step gDNA Removal and cDNA Synthesis SuperMix kits; TransStart Tip Green qPCR Super MixSYBR; Reverse Transcriptase kit; and TaqMan MGB probes (all Beijing Transgen Biotech Co., Ltd., Beijing, China) were purchased for use in the present study.
+ Open protocol
+ Expand
5

Fluorescence Microscopy Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
FISH experiments were performed as previously described54 (link),55 (link). To generate FISH probes, plasmid, cosmid, or PCR products were labeled by incorporation of Cy3-dCTP or Cy5-dCTP (GE Healthcare) with a random primer DNA labeling kit (Takara). The plasmid pRS140 and cosmid cos212 were used to prepare FISH probes against centromeres and telomeres, respectively54 (link),56 (link). FISH probes for other gene loci were generated using PCR-amplified DNA fragments (~15 kb).
IF experiments were performed as previously described52 (link),57 (link). Fixed cells were incubated with primary antibodies such as 1:10,000 diluted rabbit polyclonal anti-Myc (ab9106, Abcam) and 1:1,000 diluted mouse monoclonal anti-Pk (SV5-Pk1, Serotech). Cells were subsequently incubated with secondary antibodies such as 1:1,000 diluted Cy3-conjugated anti-mouse IgG (115-165-003, Jackson ImmunoResearch) and 1:1,000 diluted Alexa Flour 488-conjugated anti-rabbit IgG (A11034, Molecular Probes). FISH and IF images were captured using a Zeiss Axioimager Z1 fluorescence microscope with an oil immersion objective lens (Plan Apochromat, 100×, NA 1.4, Zeiss). The images were acquired at 0.2-μm intervals in the z axis controlled by Axiovision 4.6.3 software (Zeiss). More than 100 cells were analyzed for microscopic experiments.
+ Open protocol
+ Expand
6

Fluorescent Labeling of AP-site Phagemids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Similar to the previously described construction of AP-site phagemid DNA, fluorescently labeled AP-site or control phagemid DNA was prepared. During the polymerization step of the in vitro phagemid preparation, 1 nmol Cy3-dCTP (GE Life Sciences) was added to the dNTP pool generating a fraction of phagemids that were Cy3-labeled (control or AP-site-containing). In these constructs Cy3 was not placed at or around the assayed restriction site (EcoRI), whereas THF was placed in the EcoRI site. The quality of the constructs was evaluated as described in the above section. Quantification of Cy3 labeling of the phagemids was performed using an oligonucleotide containing a single Cy3 as a standard molecule to generate a standard curve and different dilutions of the phagemids. Quantification was carried out in a 96 well black plate with excitation at 480 nm and emission detected at 520 nm in a GloMax Multi-Detection system (Promega).
+ Open protocol
+ Expand
7

Array CGH Analysis of DNA Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Array CGH analysis was performed using standard methods described [5 (link)]. In brief, 300 ng of genomic DNA was labeled with Cy3-dCTP or Cy5-dCTP (GE Healthcare, Belgium) using Bioprime array CGH genomic labeling system (Invitrogen, Belgium). For the labeling, we used the “triangle method”: DNA samples from patients and controls were labeled and hybridized using a dye swap in trios consisting of at least one control per triangle. Samples were hybridized on 244K arrays (design ID 014693, Agilent, Belgium) for 40 h at 65°C. After washing, the samples were scanned at 5 μm resolution using a DNA microarray scanner G2505B (Agilent, Belgium). The scan images were analyzed using the feature extraction software 9.5.3.1 (Agilent) and further analyzed with “arrayCGHbase” [6 (link)]. Copy number variations were taken into consideration when two or more flanking probes were exceeding a value of the intensity ratios ± four times the standard deviation of log2 of all intensity ratios for that experiment. Always two experiments investigating the same sample with a dye swap were compared and only when an alteration is present in both experiments was the region included for further analysis. Inconsistencies were inspected manually.
+ Open protocol
+ Expand
8

Optimized EMSA Labelling and Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oligonucleotides used for EMSA are listed in Supplementary Table 6. For AP1, AP1m1, AP1m2, AGI-II and S-AGI, complementary single-stranded oligonucleotides were annealed in annealing buffer (10 mM Tris pH 7.5, 150 mM NaCl and 1 mM EDTA). The resulting double-stranded DNA with a protruding G was fluorescently labelled by end filling: 4 pmol of double-stranded DNA was incubated with 1 unit of Klenow fragment polymerase (Ozyme) and 8 pmol Cy3-dCTP or Cy5-dCTP (GE Healthcare) in Klenow buffer during 2 h at 37 °C, followed by 10 min enzyme inactivation at 65 °C. Binding reactions were performed in 20 μl binding buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% glycerol, 0.25 mM EDTA, 2 mM MgCl2, 0,01% Tween-20 and 3 mM TCEP) with 10 nM labelled probe, 1 × (28 ng ml−1) fish sperm DNA (Roche) as nonspecific competitor and 25–500 nM proteins.
Competition assays were performed in duplicates and 1–100 × fish sperm DNA (Roche) was used in the binding reaction. Signal quantification was performed in using ImageLab v2.0.1 (Bio-Rad Laboratories). Signal of each protein–DNA complex was quantified relatively to total DNA signal. For Fig. 4e, each binding reaction was performed in triplicate. Uncropped gels are presented as Supplementary Fig. 10.
+ Open protocol
+ Expand
9

Genomic DNA Labeling and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four hundred nanograms of genomic DNA was labeled with Cy3-dCTP (GE Healthcare, Machelen, Belgium) using a Bioprime array CGH genomic labeling system (Thermo Fisher Scientific, Waltham, MA, USA). In parallel, Kreatech gender-matched controls were labeled with Cy5-dCTP. Samples were hybridized on the custom array CGH arrays for 40 h at 65 °C. After washing, the samples were scanned at 5 µm resolution using a DNA microarray scanner, G2505B (Agilent Technologies, Santa Clara, CA, USA). The scan images were analyzed using the feature extraction software 9.5.3.1 (Agilent Technologies). Segmentation was achieved using the circular binary segmentation algorithm in the DNACopy R package. Visual inspection and creation of the copy number profile plots were performed with ‘Vivar’ [29 (link)]. All of the raw array CGH data files were made publically available through the GEO website using the accession number GSE85444.
+ Open protocol
+ Expand
10

Porcine Genome Expression Analysis via NimbleGen Microarray

Check if the same lab product or an alternative is used in the 5 most similar protocols
The RNA samples were sent to KangChen Bio-tech, China, for microarray hybridization. Each RNA sample from different PAM treatments was hybridized to one Roche NimbleGen Porcine Genome Expression Array (Roche). Briefly, double-stranded cDNA was synthesized from 6 mg of total RNA using a T7-oligo (dT) primer. The cDNA was further purified and converted into cRNA using an in vitro transcription reaction. Five mg cRNA was reverse transcribed to cDNA, fragmented, and then labeled with Cy3-dCTP (GE Healthcare) using Klenow. These labeled cDNA fragments were hybridized to NimbleGen Porcine Genome Expression Arrays for 16 h at 42°C using the Roche NimbleGen Hybridization System. Afterwards, the GeneChips were washed, stained, and then scanned with a Roche-NimbleGen MS200. The Roche NimbleGen Porcine Genome Expression Array contains over 135,000 probe sets, representing 45,023 transcripts and variants of pig from the database of RefSeq, Unigene and TIGR.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!